Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (SE:AZN)
:AZN
Earnings Data
Report Date
Feb 05, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
20.22Last Year’s EPS
19.92Same Quarter Last Year
Strong Buy
Based on 13 Analysts Ratings
Earnings Call Summary
Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflected a strong overall performance with significant revenue growth and positive trial results. However, challenges such as the impact of Medicare reforms and generic competition were noted.Company Guidance
Strong Revenue Growth
Total revenue grew by 11% in the first nine months of 2025, driven by continued demand for innovative medicines. Core EPS increased by 15%.
Robust Oncology Segment
The oncology franchise grew by 16%, reflecting strong demand across the globe, particularly in the U.S. and emerging markets.
Significant Regulatory Approvals
AstraZeneca achieved 31 regulatory approvals across key regions since February, highlighting the company's rapid pace in bringing new medicines to market.
Positive Phase III Trial Results
The company announced positive results from 16 Phase III trials, including DESTINY-Breast05, TROPION-Breast02, and Bax24.
Strong Cash Flow and Financial Health
Cash flow from operating activities increased by 37% to $12.2 billion. The net debt-to-EBITDA ratio stands at 1.2x.
SE:AZN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:AZN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 06, 2025 | kr1561.00 | kr1606.00 | +2.88% |
Jul 29, 2025 | kr1373.97 | kr1432.57 | +4.26% |
Apr 29, 2025 | kr1349.64 | kr1360.07 | +0.77% |
Feb 06, 2025 | kr1492.10 | kr1578.23 | +5.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AstraZeneca PLC (SE:AZN) report earnings?
AstraZeneca PLC (SE:AZN) is schdueled to report earning on Feb 05, 2026, Before Open (Confirmed).
What is AstraZeneca PLC (SE:AZN) earnings time?
AstraZeneca PLC (SE:AZN) earnings time is at Feb 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of AstraZeneca PLC stock?
The P/E ratio of AstraZeneca is N/A.
What is SE:AZN EPS forecast?
SE:AZN EPS forecast for the fiscal quarter 2025 (Q4) is 20.22.